Botanix Pharmaceuticals Limited
BXPHF
$0.25
$0.000.00%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 2.75% | -273.77% | -0.21% | -55.09% | 0.47% |
| Total Depreciation and Amortization | -2.75% | 1,675.36% | 0.00% | 681.48% | -3.57% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.75% | -129.87% | 0.20% | 60.07% | -0.47% |
| Change in Net Operating Assets | -- | -- | 0.21% | -- | -- |
| Cash from Operations | 2.75% | -611.57% | -0.21% | -17.19% | 0.47% |
| Capital Expenditure | 2.64% | -20.24% | 0.00% | -113.56% | 0.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.78% | 75.33% | -0.21% | 78.46% | 0.47% |
| Cash from Investing | 2.76% | 73.07% | -0.21% | 77.98% | 0.48% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00% | -99.36% | 0.00% | 155.93% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00% | -164.71% | 0.00% |
| Cash from Financing | -2.68% | -99.40% | 0.21% | 157.73% | -0.47% |
| Foreign Exchange rate Adjustments | -2.70% | -40.12% | 0.12% | 255.81% | 0.39% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.75% | -151.46% | 0.21% | 663.34% | -0.47% |
